CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $33,000 | -5.7% | 102,596 | -1.4% | 0.00% | – |
| Q1 2019 | $35,000 | +45.8% | 104,104 | +13.5% | 0.00% | – |
| Q4 2018 | $24,000 | +33.3% | 91,689 | +6.7% | 0.00% | – |
| Q3 2018 | $18,000 | -37.9% | 85,970 | -35.3% | 0.00% | – |
| Q2 2018 | $29,000 | -31.0% | 132,903 | +0.5% | 0.00% | – |
| Q1 2018 | $42,000 | – | 132,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| POPE ASSET MANAGEMENT, LLC | 2,101,626 | $546,000 | 0.40% |
| GLENHILL ADVISORS LLC | 200,000 | $52,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 10,110 | $3,000 | 0.00% |
| Citadel Advisors | 16,114 | $4,000 | 0.00% |
| Renaissance Technologies | 133,600 | $35,000 | 0.00% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 10,000 | $3,000 | 0.00% |
| Virtu KCG Holdings LLC | 27,255 | $7,000 | 0.00% |
| UBS Group AG | 50 | $0 | 0.00% |